PHAR Stock Summary and Trading Ideas (Pharming Group N.V. - Ads Each Representing 10 | NASDAQ:PHAR)

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Pharming Group N.V. - Ads Each Representing 10 trades on the NASDAQ stock market under the symbol PHAR.

As of November 13, 2026, PHAR stock price declined to $12.60 with 4,984 million shares trading.

PHAR has a beta of 0.08, meaning it tends to be less sensitive to market movements. PHAR has a correlation of 0.00 to the broad based SPY ETF.

PHAR has a market cap of $891.80 million. This is considered a Small Cap stock.

Last quarter Pharming Group N.V. - Ads Each Representing 10 reported $118 million in Revenue and $.30 earnings per share. This met revenue expectation and exceeded earnings estimates by $.07.

In the last 3 years, PHAR traded as high as $21.34 and as low as $6.65.

PHAR has underperformed the market in the last year with a return of -26.5%, while SPY returned +11.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PHAR shares. However, PHAR has outperformed the market in the last 3 month and 2 week periods, returning +6.5% and +3.9%, while SPY returned -2.1% and -1.9%, respectively. This indicates PHAR has been having a stronger performance recently.

PHAR support price is $12.34 and resistance is $13.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PHAR shares will trade within this expected range on the day.